The Elevate Campuses IPO is a closed mainboard Bookbuilding offer (Fresh capital only) that opened on 23 September 2026. The Elevate Campuses IPO closed on 25 September 2026, with an issue price of ₹362 per share. The Elevate Campuses IPO has a face value of ₹1 and a lot size of 41 shares. The Elevate Campuses IPO size aggregates up to ₹2,100 crore, listing on NSE & BSE on 30 September 2026. The Elevate Campuses IPO allotment was scheduled for 28 September 2026.
On the financial front, the Elevate Campuses IPO reported revenue of ₹603 crore for 31 Mar 2026, compared with ₹394 crore for 31 Mar 2025. The Elevate Campuses IPO PAT was ₹174 crore against ₹50 crore. The Elevate Campuses IPO EBITDA stood at ₹545 crore with a 90.32% margin. The Elevate Campuses IPO net worth as of 31 Mar 2026 was ₹956 crore.
Always verify The Elevate Campuses IPO details and GMP data with the official offer document before investing in the Elevate Campuses IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2026
31 Mar 2025
31 Mar 2024
Total Assets
5,773
2,421
2,105
Revenue
603
394
363
PAT
174
50
40
EBITDA
545
256
220
Net Worth
956
700
656
Reserves
947
698
654
Total Borrowing
4,121
1,207
985
Elevate Campuses IPO Financials FAQs
Revenue of Elevate Campuses (Amount in ₹ Crore) — 31 Mar 2026: 603; 31 Mar 2025: 394; 31 Mar 2024: 363. Profit after tax (PAT) — 31 Mar 2026: 174; 31 Mar 2025: 50; 31 Mar 2024: 40.
EBITDA of Elevate Campuses (Amount in ₹ Crore) — 31 Mar 2026: 545; 31 Mar 2025: 256; 31 Mar 2024: 220. The EBITDA margin is 90.32%.
Total assets — 31 Mar 2026: 5,773; 31 Mar 2025: 2,421; 31 Mar 2024: 2,105. Net worth — 31 Mar 2026: 956; 31 Mar 2025: 700; 31 Mar 2024: 656. Reserves & surplus — 31 Mar 2026: 947; 31 Mar 2025: 698; 31 Mar 2024: 654. (Amount in ₹ Crore)
Total borrowing of Elevate Campuses (Amount in ₹ Crore) — 31 Mar 2026: 4,121; 31 Mar 2025: 1,207; 31 Mar 2024: 985. Debt-to-equity ratio: 4.98.
The financials shown for Elevate Campuses IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.